Phosphatidylinositol 4-phosphate in the golgi apparatus regulates cell-cell adhesion and invasive cell migration in human breast cancer

Cancer Research

Volumn 74, Issue 11, 2014, Pages 3054-3066

  Tokuda, Emi ^a   Itoh, Toshiki ^a   Hasegawa, Junya ^b   Ijuin, Takeshi ^a   Takeuchi, Yukiko ^a   Irino, Yasuhiro ^a   Fukumoto, Miki ^a   Takenawa, Tadaomi ^a  

^a KOBE UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GOLGI PHOSPHOPROTEIN 3; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; PHOSPHATIDYLINOSITOL KINASE; PHOSPHOPROTEIN; UNCLASSIFIED DRUG; GOLPH3 PROTEIN, HUMAN; MEMBRANE PROTEIN; PHOSPHATIDYLINOSITOL 4-KINASE IIIBETA, HUMAN; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; PHOSPHOTRANSFERASE; POLYPHOSPHOINOSITIDE; PROTEIN BINDING;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BREAST CANCER; BREAST CANCER CELL LINE; CANCER GROWTH; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GOLGI COMPLEX; HUMAN; HUMAN CELL; METASTASIS; MOUSE; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN LOCALIZATION; BREAST TUMOR; CELL MOTION; DISEASE COURSE; GENETICS; MCF 7 CELL LINE; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL MOVEMENT; DISEASE PROGRESSION; FEMALE; GOLGI APPARATUS; HUMANS; MCF-7 CELLS; MEMBRANE PROTEINS; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROTEIN BINDING;

EID: 84902158945     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-13-2441     Document Type: Article

References (45)

1. Vicinanza M, D'Angelo G, Di Campli A, De Matteis MA. Function and dysfunction of the PI system in membrane trafficking. EMBO J 2008;27:2457-70.
2. Skwarek LC, Boulianne GL. Great expectations for PIP: phosphoinositides as regulators of signaling during development and disease. Dev Cell 2009;16:12-20.
3. Graham TR, Burd CG. Coordination of Golgi functions by phosphatidylinositol 4-kinases. Trends Cell Biol 2011;21:113-21.
4. Wang YJ, Wang J, Sun HQ, Martinez M, Sun YX, Macia E, et al. Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1 complexes to the Golgi. Cell 2003;114:299-310.
5. Yeaman C, Ayala MI, Wright JR, Bard F, Bossard C, Ang A, et al. Protein kinase D regulates basolateral membrane protein exit from trans-Golgi network. Nat Cell Biol 2004;6:106-12.
6. Mayinger P. Regulation of Golgi function via phosphoinositide lipids. Semin Cell Dev Biol 2009;20:793-800.
7. D'Angelo G, Vicinanza M, Di Campli A, De Matteis MA. The multiple roles of PtdIns(4)P-not just the precursor of PtdIns(4, 5)P2. J Cell Sci 2008;121:1955-63.
8. Wood CS, Schmitz KR, Bessman NJ, Setty TG, Ferguson KM, Burd CG. PtdIns4P recognition by Vps74/GOLPH3 links PtdIns 4-kinase signaling to retrograde Golgi trafficking. J Cell Biol 2009;187:967-75.
9. Dippold HC, Ng MM, Farber-Katz SE, Lee SK, Kerr ML, Peterman MC, et al. GOLPH3 bridges phosphatidylinositol-4- phosphate and actomyosin to stretch and shape the Golgi to promote budding. Cell 2009;139:337-51.
10. Scott KL, Kabbarah O, Liang MC, Ivanova E, Anagnostou V, WuJ, et al. GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature 2009;459:1085-90.
11. Li XY, Liu W, Chen SF, Zhang LQ, Li XG, Wang LX. Expression of the Golgi phosphoprotein-3 gene in human gliomas: A pilot study. J Neurooncol 2011;105:159-63.
12. Kunigou O, Nagao H, Kawabata N, Ishidou Y, Nagano S, Maeda S, et al. Role of GOLPH3 and GOLPH3L in the proliferation of human rhabdomyosarcoma. Oncol Rep 2011;26:1337-42.
13. Li H, Guo L, Chen SW, Zhao XH, Zhuang SM, Wang LP, et al. GOLPH3 overexpression correlates with tumor progression and poor prognosis in patients with clinically No oral tongue cancer. J Transl Med 2012;10:168.
14. Hua X, Yu L, Pan W, Huang X, Liao Z, Xian Q, et al. Increased expression of Golgi phosphoprotein-3 is associated with tumor aggressiveness and poor prognosis of prostate cancer. Diagn Pathol 2012;7:127.
15. Zeng Z, Lin H, Zhao X, Liu G, Wang X, Xu R, et al. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor. Clin Cancer Res 2012;18:4059-69.
16. Nieto MA. The ins and outs of the epithelial to mesenchymal transition in health and disease. Annu Rev Cell Dev Biol 2011;27: 347-76.
17. Nieto MA, Cano A. The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol 2012;22:361-8.
18. Furutani M, Tsujita K, Itoh T, Ijuin T, Takenawa T. Application of phosphoinositide-binding domains for the detection and quantification of specific phosphoinositides. Anal Biochem 2006;355:8-18.
19. Hasegawa J, Tokuda E, Tenno T, Tsujita K, Sawai H, Hiroaki H, et al. SH3YL1 regulates dorsal ruffle formation by a novel phosphoinositidebinding domain. J Cell Biol 2011;193:901-16.
20. Lion M, Bisio A, Tebaldi T, De Sanctis V, Menendez D, Resnick MA, et al. Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics. Cell Cycle 2013;12: 1211-24.
21. Qiao M, Sheng S, Pardee AB. Metastasis and AKT activation. Cell Cycle 2008;7:2991-6.
22. Ye Y, Jin L, Wilmott JS, Hu WL, Yosufi B, Thorne RF, et al. PI(4, 5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma. Nat Commun 2013;4: 1508.
23. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009;28:15-33.
24. Hammond GR, Schiavo G, Irvine RF. Immunocytochemical techniques reveal multiple, distinct cellular pools of PtdIns4P and PtdIns(4, 5)P(2). Biochem J 2009;422:23-35.
25. Burk U, Schubert J, Wellner U, Schmalhofer O, Vincan E, Spaderna S, et al. A reciprocal repression between ZEB1 and members of the miR- 200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008;9:582-9.
26. Ruike Y, Imanaka Y, Sato F, Shimizu K, Tsujimoto G. Genome-wide analysis of aberrant methylation in human breast cancer cells using methyl-DNA immunoprecipitation combined with high-throughput sequencing. BMC Genomics 2010;11:137.
27. Pishvaian MJ, Feltes CM, Thompson P, Bussemakers MJ, Schalken JA, Byers SW. Cadherin-11 is expressed in invasive breast cancer cell lines. Cancer Res 1999;59:947-52.
28. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ. N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 1999;147:631-44.
29. Cleves AE, Novick PJ, Bankaitis VA. Mutations in the SAC1 gene suppress defects in yeast Golgi and yeast actin function. J Cell Biol 1989;109:2939-50.
30. Liu Y, Boukhelifa M, Tribble E, Bankaitis VA. Functional studies of the mammalian Sac1 phosphoinositide phosphatase. Adv Enzyme Regul 2009;49:75-86.
31. Whitters EA, Cleves AE, McGee TP, Skinner HB, Bankaitis VA. SAC1p is an integral membrane protein that influences the cellular requirement for phospholipid transfer protein function and inositol in yeast. J Cell Biol 1993;122:79-94.
32. Migita T, Inoue S. Implications of the Golgi apparatus in prostate cancer. Int J Biochem Cell Biol 2012;44:1872-6.
33. Durrant LG, Noble P, Spendlove I. Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapy. Clin Exp Immunol 2012;167:206-15.
34. Schmitz KR, Liu J, Li S, Setty TG, Wood CS, Burd CG, et al. Golgi localization of glycosyltransferases requires a Vps74p oligomer. Dev Cell 2008;14:523-34.
35. Tu L, Tai WC, Chen L, Banfield DK. Signal-mediated dynamic retention of glycosyltransferases in the Golgi. Science 2008;321:404-7.
36. Wood CS, Hung CS, Huoh YS, Mousley CJ, Stefan CJ, Bankaitis V, et al. Local control of phosphatidylinositol 4-phosphate signaling in the Golgi apparatus by Vps74 and Sac1 phosphoinositide phosphatase. Mol Biol Cell 2012;23:2527-36.
37. Tarin D, Thompson EW, Newgreen DF. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005;65:5996-6000; discussion -1.
38. Drasin DJ, Robin TP, Ford HL. Breast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticity. Breast Cancer Res 2011;13:226.
39. Wicki A, Lehembre F, Wick N, Hantusch B, Kerjaschki D, Christofori G. Tumor invasion in the absence of epithelial-mesenchymal transition: podoplanin-mediated remodeling of the actin cytoskeleton. Cancer cell 2006;9:261-72.
40. Hidalgo-Carcedo C, Hooper S, Chaudhry SI, Williamson P, Harrington K, Leitinger B, et al. Collective cell migration requires suppression of actomyosin at cell-cell contacts mediated by DDR1 and the cell polarity regulators Par3 and Par6. Nat Cell Biol 2011;13:49-58.
41. Nagaharu K, Zhang X, Yoshida T, Katoh D, Hanamura N, Kozuka Y, et al. Tenascin C induces epithelial-mesenchymal transition-like change accompanied by SRC activation and focal adhesion kinase phosphorylation in human breast cancer cells. Am J Pathol 2011;178:754-63.
42. Christiansen JJ, Rajasekaran AK. Reassessing epithelial to mesenchymal transition as a prerequisite for carcinoma invasion and metastasis. Cancer Res 2006;66:8319-26.
43. Zhou JX, Xu T, Qin R, Yan Y, Chen C, Chen YY, et al. Overexpression of Golgi phosphoprotein-3 (GOLPH3) in glioblastoma multiforme is associated with worse prognosis. J NeuroOncol 2012;110: 195-203.
44. Zhou X, Zhan W, Bian W, Hua L, Shi Q, Xie S, et al. GOLPH3 regulates the migration and invasion of glioma cells though Rho A. Biochem Biophys Res Commun 2013;433:338-44.
45. Yilmaz M, Christofori G. EMT the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev 2009;28:15-33.